Vivos Therapeutics, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Vivos Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Vivos Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $100K, unchanged year-over-year.
  • Vivos Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $600K, a 20% increase year-over-year.
  • Vivos Therapeutics, Inc. annual Depreciation for 2023 was $700K, a 16.7% increase from 2022.
  • Vivos Therapeutics, Inc. annual Depreciation for 2022 was $600K, a 50% increase from 2021.
  • Vivos Therapeutics, Inc. annual Depreciation for 2021 was $400K, a 33.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $700K +$100K +16.7% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-07-30
2022 $600K +$200K +50% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-07-30
2021 $400K +$100K +33.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $300K -$26.8K -8.21% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $327K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.